Itau Unibanco Holding S.A. United Therapeutics Corp Transaction History

Itau Unibanco Holding S.A.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$203.3 - $244.17 $27,852 - $33,451	-137 Reduced 34.6%	259 $54,000
Q4 2021 Feb 14, 2022	BUY	$184.32 - $216.08 $2,396 - $2,809	13 Added 3.39%	396 $85,000
Q3 2021 Nov 12, 2021	BUY	$179.86 - $214.88 $24,460 - $29,223	136 Added 55.06%	383 $71,000
Q2 2021 Aug 17, 2021	BUY	$170.47 - $211.93 $42,106 - $52,346	247 New	247 $44,000
Q4 2018 Feb 13, 2019	SELL	$101.4 - $128.73 $98,865 - $125,511	-975 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$113.81 - $129.46 $35,508 - $40,391	312 Added 47.06%	975 $125,000
Q2 2018 Aug 13, 2018	SELL	$101.14 - $118.31 $214,619 - $251,053	-2,122 Reduced 76.19%	663 $75,000
Q1 2018 May 14, 2018	SELL	$107.21 - $151.94 $141,195 - $200,104	-1,317 Reduced 32.11%	2,785 $313,000
Q4 2017 Feb 09, 2018	SELL	$118.58 - $151.28 $104,113 - $132,823	-878 Reduced 17.63%	4,102 $607,000
Q3 2017 Nov 14, 2017	BUY	$114.6 - $136.81 $570,708 - $681,313	4,980	4,980 $1.85 Million

676

42.1M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.3B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Itau Unibanco Holding S.A. with notifications on news.